Cargando…
Use of Hydralazine‐Isosorbide Dinitrate Combination in African American and Other Race/Ethnic Group Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction
BACKGROUND: Hydralazine‐isosorbide dinitrate (H‐ISDN) therapy is recommended for African American patients with moderate to severe heart failure with reduced ejection fraction (<40%) (HFrEF), but use, temporal trends, and clinical characteristics associated with H‐ISDN therapy in clinical practic...
Autores principales: | Golwala, Harsh B., Thadani, Udho, Liang, Li, Stavrakis, Stavros, Butler, Javed, Yancy, Clyde W., Bhatt, Deepak L., Hernandez, Adrian F., Fonarow, Gregg C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828812/ https://www.ncbi.nlm.nih.gov/pubmed/23966379 http://dx.doi.org/10.1161/JAHA.113.000214 |
Ejemplares similares
-
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure
por: Echols, Melvin R, et al.
Publicado: (2006) -
Hydralazine–Isosorbide Dinitrate Use in Patients With End-Stage Kidney Disease on Dialysis
por: Mavrakanas, Thomas A., et al.
Publicado: (2022) -
Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross‐European survey
por: Brewster, Lizzy M.
Publicado: (2019) -
Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction
por: Zamani, Payman, et al.
Publicado: (2017) -
Eco-friendly estimation of isosorbide dinitrate and hydralazine hydrochloride using Green Analytical Quality by Design-based UPLC Method
por: Chanduluru, Hemanth Kumar, et al.
Publicado: (2021)